Skip to content
Press Release
FEATURED | May 1, 2026

Jason Chambers Teams Up with the Melanoma Researc...

Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...

5 Minute Read
December 19, 2023

Understand metastasis of uveal melanoma in vivo vi...

Uveal melanoma (UM) is the most common eye cancer in adults which originates from pigmented cells in the uvea of the eye. The major challenge in UM treatment is the high fr...

1 Minute Read
December 19, 2023

Evaluation of cutaneous immune related adverse eve...

The treatment of melanoma with checkpoint inhibitor (CPI) therapy has produced rapid and substantial gains in survival, and as a result, the indications for its use have st...

3 Minute Read
December 19, 2023

Identification of molecular pathways that drive uv...

Uveal melanoma (UM) is a type of aggressive eye cancer that often spreads to the liver and has a poor prognosis. We don’t fully understand how UM spreads, which makes it ...

2 Minute Read
February 24, 2023

Exploring Biomarkers of Response to Combined CTLA-...

BC Pilot – James W. Smithy, MD, MHS

1 Minute Read
February 24, 2023

SMR Christopher J. Marshall Award

SMR Christopher J. Marshall Award – Sydney Shaffer, MD, PhD

1 Minute Read
February 24, 2023

SMR Young Investigator Award

SMR Young Investigator Award – Benjamin Izar, MD, PhD

1 Minute Read
February 24, 2023

Efficacy of adjuvant therapy in patients (pts) wit...

MRF Endowed Merit Award (ASCO) – Piyush Grover, MBBS, B.Pharm

1 Minute Read

Dec 10, 2026 ET

Webinar | State of Melanoma: Prevention Policy

Dec 12, 2026 ET

Fort Myers Miles for Melanoma 5K

Feb 07, 2027 ET

Miami Miles for Melanoma 5K

Mar 07, 2027 ET - Mar 09, 2027

2027 Advocacy Days

Apr 16, 2027 MT - Apr 18, 2027

2027 Eyes on a Cure: Ocular Melanoma Patient & Caregiver Symposium

Explore Events